Pharma Focus Asia

Catalent Announces Completion of First Phase of US$7.3 Million Expansion


Catalent Pharma Solutions announced the completion of the first phase of a US$7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy.


The first phase of investment, which was completed in August 2018, witnessed the expansion and upgrade of the facility's integrated packaging capabilities, and the commissioning of the first of five new softgel encapsulation lines.

The second phase of the investment will add four encapsulation lines, which will bring the total number of lines to 23.

It will significantly expand production, drying, and inspection capacity for nutritional supplements and beauty softgels at the site.

It is expected that these four new lines will be fully operational by January 2019.

The investment is driven by increasing demand for nutritional and beauty products globally.

It will also enable Catalent to better serve these markets.


NameCatalent Pharma Solutions
BudgetUS$7.3 million
Parties InvolvedCatalent Pharma Solutions
ScheduleScheduled to be operational by 2019
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference